Pa
PathAI
Boston MAFounded 2016300 employees
Private CapbiotechPrivateOncology
Platform: AI Pathology
Market Cap
N/A
All Drugs
4
Clinical Trials
8
Failed / Terminated
1
FDA Approved
1
Drug Pipeline (4 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Ivotenlimab | PAT-1077 | Approved | 2 | ALK | PsA | ||
| Polanaritide | PAT-2359 | Phase 1/2 | 1 | C5 | MGMCC | ||
| PAT-6991 | PAT-6991 | Phase 1/2 | 2 | CDK2 | RAMCL | ||
| Fixatuximab | PAT-3676 | Phase 3 | 3 | JAK1 | Epilepsy |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (7)